Re: Presentation

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Presentation

in response to

Re: Presentation

Hartland

posted on Nov 03, 2017 10:58AM

"Great if both continue to float but the results seem to give Zenith the edge especially as they are working with known drugs."

An edge in what sense?

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply